These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19447866)

  • 1. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.
    Denzel MS; Hebbard LW; Shostak G; Shapiro L; Cardiff RD; Ranscht B
    Clin Cancer Res; 2009 May; 15(10):3256-64. PubMed ID: 19447866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo.
    Landskroner-Eiger S; Qian B; Muise ES; Nawrocki AR; Berger JP; Fine EJ; Koba W; Deng Y; Pollard JW; Scherer PE
    Clin Cancer Res; 2009 May; 15(10):3265-76. PubMed ID: 19447867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
    Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB
    Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
    Rao T; Ranger JJ; Smith HW; Lam SH; Chodosh L; Muller WJ
    Breast Cancer Res; 2014 Jan; 16(1):R11. PubMed ID: 24457046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.
    Decock J; Hendrickx W; Thirkettle S; Gutiérrez-Fernández A; Robinson SD; Edwards DR
    Breast Cancer Res; 2015 Mar; 17(1):38. PubMed ID: 25848906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model.
    Hebbard LW; Garlatti M; Young LJ; Cardiff RD; Oshima RG; Ranscht B
    Cancer Res; 2008 Mar; 68(5):1407-16. PubMed ID: 18316604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression.
    Huck L; Pontier SM; Zuo DM; Muller WJ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15559-64. PubMed ID: 20713705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
    Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP
    Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
    Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
    Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic acceleration of Neu induced mammary tumor progression and metastasis.
    Oshima RG; Lesperance J; Munoz V; Hebbard L; Ranscht B; Sharan N; Muller WJ; Hauser CA; Cardiff RD
    Cancer Res; 2004 Jan; 64(1):169-79. PubMed ID: 14729621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic Polyoma middle-T mice model premalignant mammary disease.
    Maglione JE; Moghanaki D; Young LJ; Manner CK; Ellies LG; Joseph SO; Nicholson B; Cardiff RD; MacLeod CL
    Cancer Res; 2001 Nov; 61(22):8298-305. PubMed ID: 11719463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice.
    Niemeyer CC; Spencer-Dene B; Wu JX; Adamson ED
    Int J Cancer; 1999 May; 81(4):588-91. PubMed ID: 10225449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of vascular and progenitor cell compartments in tumours from MMTV-PyVmT transgenic mice during mammary cancer progression.
    Smith MJ; Berger RW; Minhas K; Moorehead RA; Coomber BL
    Int J Exp Pathol; 2011 Apr; 92(2):106-16. PubMed ID: 21059124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer.
    Chen M; Shabashvili D; Nawab A; Yang SX; Dyer LM; Brown KD; Hollingshead M; Hunter KW; Kaye FJ; Hochwald SN; Marquez VE; Steeg P; Zajac-Kaye M
    Mol Cancer Ther; 2012 Feb; 11(2):370-82. PubMed ID: 22203734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors.
    Cleary MP; Juneja SC; Phillips FC; Hu X; Grande JP; Maihle NJ
    Exp Biol Med (Maywood); 2004 Feb; 229(2):182-93. PubMed ID: 14734797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis.
    Al Masri A; Gendler SJ
    Oncogene; 2005 Sep; 24(38):5799-808. PubMed ID: 15897873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation.
    Gerstel D; Wegwitz F; Jannasch K; Ludewig P; Scheike K; Alves F; Beauchemin N; Deppert W; Wagener C; Horst AK
    Oncogene; 2011 Oct; 30(41):4275-88. PubMed ID: 21532628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
    Maroulakou IG; Oemler W; Naber SP; Tsichlis PN
    Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression.
    Heckman-Stoddard BM; Vargo-Gogola T; McHenry PR; Jiang V; Herrick MP; Hilsenbeck SG; Settleman J; Rosen JM
    Breast Cancer Res; 2009; 11(4):R61. PubMed ID: 19703301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.